(Reuters) -U.S. drugmaker Pfizer (NYSE:) stated on Wednesday it's withdrawing its sickle cell illness remedy Oxbryta from all markets the place it's authorised, citing dangers of a painful complication and...
By Rae Wee and Linda Pasquini LONDON/SINGAPORE (Reuters) -The euro rose barely towards the greenback on Wednesday whereas the yuan hit its strongest stage in over a yr, as China's aggressive stimulus...
By Rajesh Kumar Singh (Reuters) - Activist investor Elliott Funding Administration on Tuesday escalated its boardroom battle with Southwest Airways (NYSE:), saying it plans to name a particular shareholder assembly as quickly...
By Chuck Mikolajczak NEW YORK (Reuters) -China's yuan hit a 16-month excessive towards the U.S. greenback on Tuesday, after the central financial institution of the world's second-largest financial system revealed new stimulus...
By Allison Lampert and David Shepardson (Reuters) -Boeing made a "finest and remaining" pay supply to hundreds of hanging staff on Monday, however its largest union declined to place it to a...
By Sruthi Shankar and Vidya Ranganathan LONDON/SINGAPORE (Reuters) - The euro fell sharply towards the greenback on Monday, as enterprise exercise readings painted a grim image of the euro zone financial system...
